The Premier Consumer Advocate For Victims Of Recalled Drugs
       Or Defective Medical Devices In The United States


 HomeAboutServicesPress ReleaseContact


zoloftProzac, Zoloft Birth Defects

Taking the anti depressants Prozac or Zoloft while pregnant can increase the risk of the baby having severe birth defects." The US Drug Watchdog Says, "These birth defects include, Persistent Pulmonary Hypertension of the Newborn (or PPHN). PPHN restricts blood flow and reduces the amount of oxygen in the blood, and Craniosynostosis - premature closing of sutures between the skull bones in infants, restricting brain growth and development. These birth defects are unbelievably horrible, and we want to identify every victim of these specific birth defects.

The US Drug Watchdog says, "While new drugs are introduced to improve our lives, you must be informed of possible risks. Unfortunately if you took Prozac or Zoloft while pregnant you may have not been warned of the risk of birth defects. We need to get the word out to all US mothers, who were using Prozac, or Zoloft while they were pregnant, especially if their baby had a severe birth defect."


  The US Drug Watchdog specifically indicates the following birth defects may apply to babies, whose mothers were using Prozac, or Zoloft while pregnant.
  • Rapid Breathing
  • Rapid Heart Rate
  • Difficulty Breathing
  • Bluish Skin
  • Heart Murmurs
  • Low Blood Oxygen Levels

The US Drug Watchdog Says, "Persistent Pulmonary Hypertension of the Newborn, also known as PPHN can be generalized as the baby's respiration system not adjusting to life outside the womb. As such, PPHN is generally noticed by doctors shortly after birth, but 10-20 percent of babies diagnosed with PPHN die despite treatment. If you took Zoloft or Prozac while pregnant and your child is experiencing any of the following symptoms, they may have PPHN, and we want to hear from you. For more information please call the US Drug Watchdog anytime at 866-714-6466.



Call anytime


National Advocacy Group for Consumer Protection and Corporate Fair Play




Copyright 2012 US Drug Watchdog